Klin Onkol 2004; 17(Suppl 1): 49-50.
Summary: The paper generally summarizes rules for correct and early cancer diagnostics as key component determining therapeutic strategy and reached results. A minimum optimized set of parameters for evaluation of diagnostics in health technology assessment process is proposed. Relevant data entry must include time parameters in relation to the therapy, risk evaluation of patient (clinical staging, prognostic factors, biomarkers) and time-related evaluation of patient after the end of specified therapeutic episode. Continuous diagnostic monitoring is necessary due to possible risk events like relapse or disease progression.
